~~<i id='4D67846504'><strike id='4D67846504'><tt id='4D67846504'><pre id='4D67846504'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：leisure time 2025-09-06 03:55:27 - browse：65839

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The high cost of giving birth even with insurance

focus

knowledge

entertainment

knowledge

hotspot

leisure time

AdobeInourrolesatMedTechInnovator,aglobalacceleratorformedtechstartups,we’veworkedwiththousandsofear

WSS

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Vertex non

New clues to why women have higher risk of autoimmune disorders

10 reasons why health care startups fail

Humana’s losses in Medicare Advantage tank its stock

New air purifier tech could be key to improving indoor air quality

hotspot

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

Merck CEO won’t testify in Senate, citing no expertise in drug prices

After affirmative action ruling, medical educators look to 'holistic review'

Peter Hotez and the public health issue of online harassment

Hepatitis C has a cure — but many Americans still lack access to it

Medicare drug price negotiation legal challenge met with skepticism

Medicare details structure of new drug price negotiation program

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

In Memoriam: Notable people who died in 2023

George Santos makes 1st court appearance after pleading not guilty to 13 counts

knowledge

Guidelines to prevent youth baseball injuries need more muscle

New clues to why women have higher risk of autoimmune disorders

What does generative AI mean for health care? We asked experts

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Apple is now the first public company to be valued at $3 trillion

After affirmative action ruling, medical educators look to 'holistic review'

entertainment

knowledge

hotspot

leisure time